Quoin shareholders lift ownership cap to 9.99%
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
Quoin Pharmaceuticals shareholders approved an amendment raising beneficial ownership limits for investors in recent private placements from 4.99% to 9.99%, decided at a Special General Meeting. The company faces financial challenges, with shares down significantly over the past year. Canaccord Genuity and BTIG initiated buy ratings, citing lead rare dermatology program QRX003 for Netherton syndrome.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.